Worksport (NASDAQ:WKSP – Get Free Report) and Aspire Biopharma (NASDAQ:ASBP – Get Free Report) are both small-cap consumer discretionary companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability and analyst recommendations.
Insider and Institutional Ownership
16.1% of Worksport shares are held by institutional investors. Comparatively, 19.2% of Aspire Biopharma shares are held by institutional investors. 5.8% of Worksport shares are held by company insiders. Comparatively, 5.8% of Aspire Biopharma shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Analyst Recommendations
This is a summary of current ratings for Worksport and Aspire Biopharma, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Worksport | 1 | 0 | 1 | 0 | 2.00 |
| Aspire Biopharma | 1 | 0 | 0 | 0 | 1.00 |
Risk & Volatility
Worksport has a beta of 0.41, suggesting that its stock price is 59% less volatile than the S&P 500. Comparatively, Aspire Biopharma has a beta of 0.17, suggesting that its stock price is 83% less volatile than the S&P 500.
Valuation & Earnings
This table compares Worksport and Aspire Biopharma”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Worksport | $16.10 million | 0.46 | -$19.35 million | ($2.34) | -0.16 |
| Aspire Biopharma | $10,000.00 | 1,142.40 | -$24.48 million | ($69.62) | -0.12 |
Worksport has higher revenue and earnings than Aspire Biopharma. Worksport is trading at a lower price-to-earnings ratio than Aspire Biopharma, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Worksport and Aspire Biopharma’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Worksport | -114.49% | -102.57% | -73.69% |
| Aspire Biopharma | -11,362.21% | N/A | -177.59% |
Summary
Worksport beats Aspire Biopharma on 10 of the 13 factors compared between the two stocks.
About Worksport
Worksport Ltd., through its subsidiary, designs and distributes truck tonneau covers in Canada and the United States. The company offers soft tonneau covers, such as vinyl wrapped tri- and quad-fold tonneau covers; and hard tonneau covers, including tri- and quad-fold aluminum covers. It also offers energy products, such as Worksport SOLIS, a tonneau cover with integrated solar panels; and Worksport COR energy storage system, a modular, portable power station. It serves its products to automotive accessories, consumer electronics, and residential and commercial HVAC system markets. The company also sells its products through wholesalers, private labels, distributors, and online retail channels, including eBay, Amazon, Walmart, and e-commerce platform hosted on Shopify. Worksport Ltd. is based in West Seneca, New York.
About Aspire Biopharma
Aspire Biopharma Holdings, Inc., early-stage biopharmaceutical company, engages in developing and marketing of disruptive technology for delivery mechanisms for do no harm drugs in the United States. The company provides Sublingual Aspirin Product, which addresses cardiology emergencies and pain management. It develops formulation for a sublingually administered melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide, as well as formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and several other classes of drugs. The company was founded in 2021 and is based in Humacao, Puerto Rico.
Receive News & Ratings for Worksport Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Worksport and related companies with MarketBeat.com's FREE daily email newsletter.
